On the public citation graph
Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking
0 signed · 114 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/elps.200900140openalex-snapshot
Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective
inferredcites →https://doi.org/10.1002/gch2.1018openalex-snapshot
Data, disease and diplomacy: GISAID's innovative contribution to global health
inferredcites →https://doi.org/10.1002/jcc.21334openalex-snapshot
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
inferredcites →https://doi.org/10.1002/prot.21086openalex-snapshot
ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibility
inferredcites →https://doi.org/10.1007/978-1-61779-465-0_10openalex-snapshot
Rosetta Ligand Docking with Flexible XML Protocols
inferredcites →https://doi.org/10.1016/j.antiviral.2013.09.015openalex-snapshot
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
inferredcites →https://doi.org/10.1016/j.jmb.2008.11.010openalex-snapshot
RosettaLigand Docking with Full Ligand and Receptor Flexibility
inferredcites →https://doi.org/10.1038/s41467-019-10280-3openalex-snapshot
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
inferredcites →https://doi.org/10.1038/s41598-017-09654-8openalex-snapshot
Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology
inferredcites →https://doi.org/10.1093/bioinformatics/btq662openalex-snapshot
Toward the estimation of the absolute quality of individual protein structure models
inferredcites →https://doi.org/10.1093/nar/gkw1132openalex-snapshot
The SWISS-MODEL Repository—new features and functionality
inferredcites →https://doi.org/10.1093/nar/gky1049openalex-snapshot
UniProt: a worldwide hub of protein knowledge
inferredcites →https://doi.org/10.1093/nar/gky427openalex-snapshot
SWISS-MODEL: homology modelling of protein structures and complexes
inferredcites →https://doi.org/10.1093/nar/gky473openalex-snapshot
CASTp 3.0: computed atlas of surface topography of proteins
inferredcites →https://doi.org/10.1128/mbio.00221-18openalex-snapshot
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
inferredcites →https://doi.org/10.1177/2040206618761299openalex-snapshot
Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses
inferredcites →https://doi.org/10.1186/s13321-019-0372-5openalex-snapshot
Fast, efficient fragment-based coordinate generation for Open Babel
inferredcites →https://doi.org/10.20944/preprints202002.0242.v2openalex-snapshot
Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking
inferredcites →https://doi.org/10.2147/hiv.s79956openalex-snapshot
HIV protease inhibitors: a review of molecular selectivity and toxicity
inferredcites →https://doi.org/10.2147/tcrm.s3285openalex-snapshot
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/cbf.3576openalex-snapshot
Potential small‐molecule drugs as available weapons to fight novel coronavirus ( 2019‐nCoV ): A review
inferred← citeshttps://doi.org/10.1002/jcp.30076openalex-snapshot
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
inferred← citeshttps://doi.org/10.1002/jmv.25893openalex-snapshot
Evaluation of antiviral therapies for coronavirus disease 2019 pneumonia in Shanghai, China
inferred← citeshttps://doi.org/10.1007/978-981-15-6006-4_4openalex-snapshot
Differential Diagnosis and Possible Therapeutics for Coronavirus Disease 2019
inferred← citeshttps://doi.org/10.1007/s10989-020-10115-6openalex-snapshot
Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease
inferred← citeshttps://doi.org/10.1007/s13205-021-02644-8openalex-snapshot
Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104490openalex-snapshot
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
inferred← citeshttps://doi.org/10.1016/j.biopha.2020.110694openalex-snapshot
Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111544openalex-snapshot
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
inferred← citeshttps://doi.org/10.1016/j.cegh.2020.07.006openalex-snapshot
Antivirals for COVID-19: A critical review
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.105183openalex-snapshot
Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
inferred← citeshttps://doi.org/10.1016/j.crphar.2021.100057openalex-snapshot
Recent progress in the development of potential drugs against SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.10.018openalex-snapshot
Union is strength: antiviral and anti-inflammatory drugs for COVID-19
inferred← citeshttps://doi.org/10.1016/j.ejpb.2020.11.024openalex-snapshot
siRNA delivery to macrophages using aspherical, nanostructured microparticles as delivery system for pulmonary administration
inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.173642openalex-snapshot
Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e08496openalex-snapshot
SARS-CoV-2 at the human-animal interface: A review
inferred← citeshttps://doi.org/10.1016/j.jics.2021.100328openalex-snapshot
In silico study of remdesivir with and without ionic liquids having different cations using DFT calculations and molecular docking
inferred← citeshttps://doi.org/10.1016/j.jiph.2020.10.015openalex-snapshot
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
inferred← citeshttps://doi.org/10.1016/j.jiph.2021.01.016openalex-snapshot
Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents
inferred← citeshttps://doi.org/10.1016/j.jksus.2021.101707openalex-snapshot
Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.jmgm.2020.107730openalex-snapshot
Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2–P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach
inferred← citeshttps://doi.org/10.1016/j.jmgm.2020.107758openalex-snapshot
An in-silico evaluation of COVID-19 main protease with clinically approved drugs
inferred← citeshttps://doi.org/10.1016/j.jphotobiol.2020.111997openalex-snapshot
Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118205openalex-snapshot
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study
inferred← citeshttps://doi.org/10.1016/j.molstruc.2020.128878openalex-snapshot
Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking
inferred← citeshttps://doi.org/10.1016/j.molstruc.2020.129143openalex-snapshot
Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
inferred← citeshttps://doi.org/10.1016/j.nmni.2021.100878openalex-snapshot
Computational insights of phytochemical-driven disruption of RNA-dependent RNA polymerase-mediated replication of coronavirus: a strategic treatment plan against coronavirus disease 2019
inferred← citeshttps://doi.org/10.1016/j.virusres.2020.198073openalex-snapshot
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00326openalex-snapshot
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00517openalex-snapshot
De Novo Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization
inferred← citeshttps://doi.org/10.1021/acs.jpcb.0c04198openalex-snapshot
Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase
inferred← citeshttps://doi.org/10.1038/s41591-020-0883-7openalex-snapshot
Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy
inferred← citeshttps://doi.org/10.1038/s41598-021-84637-4openalex-snapshot
Potential neutralizing antibodies discovered for novel corona virus using machine learning
inferred← citeshttps://doi.org/10.1080/03602532.2020.1845201openalex-snapshot
Recent biotechnological approaches for treatment of novel COVID-19: from bench to clinical trial
inferred← citeshttps://doi.org/10.1080/07391102.2020.1772108openalex-snapshot
Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M pro ) of SARS-CoV-2 and inhibit its activity
inferred← citeshttps://doi.org/10.1080/07391102.2020.1772112openalex-snapshot
Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
inferred← citeshttps://doi.org/10.1080/07391102.2020.1775704openalex-snapshot
Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
inferred← citeshttps://doi.org/10.1080/07391102.2020.1824816openalex-snapshot
Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches
inferred← citeshttps://doi.org/10.1080/07391102.2020.1834457openalex-snapshot
Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds
inferred← citeshttps://doi.org/10.1080/07391102.2020.1835732openalex-snapshot
Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2
inferred← citeshttps://doi.org/10.1080/07391102.2021.1940281openalex-snapshot
Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus
inferred← citeshttps://doi.org/10.1080/07391102.2022.2029770openalex-snapshot
An investigation for the interaction of gamma oryzanol with the Mpro of SARS-CoV-2 to combat COVID-19: DFT, molecular docking, ADME and molecular dynamics simulations
inferred← citeshttps://doi.org/10.1080/17460441.2020.1811676openalex-snapshot
A public-private partnership for the express development of antiviral leads: a perspective view
inferred← citeshttps://doi.org/10.1080/25765299.2020.1836812openalex-snapshot
A review on clinical, pathological characteristics and drug designing for COVID-19
inferred← citeshttps://doi.org/10.1093/bib/bbaa209openalex-snapshot
Potential inhibitors for the novel coronavirus (SARS-CoV-2)
inferred← citeshttps://doi.org/10.1093/pcmedi/pbab001openalex-snapshot
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
inferred← citeshttps://doi.org/10.1101/2020.03.18.20038117openalex-snapshot
Predicting the epidemic trend of COVID-19 in China and across the world using the machine learning approach
inferred← citeshttps://doi.org/10.1109/uemcon53757.2021.9666715openalex-snapshot
A Conceptual Deep Learning Framework for COVID-19 Drug Discovery
inferred← citeshttps://doi.org/10.1186/s12967-020-02344-6openalex-snapshot
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
inferred← citeshttps://doi.org/10.1186/s43141-022-00375-8openalex-snapshot
Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors
inferred← citeshttps://doi.org/10.12688/f1000research.24218.1openalex-snapshot
Coronavirus disease 2019 drug discovery through molecular docking
inferred← citeshttps://doi.org/10.14499/indonesianjcanchemoprev11iss3pp154-167openalex-snapshot
The Chemopreventive Potential of Diosmin and Hesperidin for COVID-19 and Its Comorbid Diseases
inferred← citeshttps://doi.org/10.1515/znc-2021-0306openalex-snapshot
Insighting the optoelectronic, charge transfer and biological potential of benzo-thiadiazole and its derivatives
inferred← citeshttps://doi.org/10.15190/d.2020.5openalex-snapshot
COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus
inferred← citeshttps://doi.org/10.1590/1519-6984.247604openalex-snapshot
A threefold approach including quantum chemical, molecular docking and molecular dynamic studies to explore the natural compounds from Centaurea jacea as the potential inhibitors for COVID-19
inferred← citeshttps://doi.org/10.1590/1678-4685-gmb-2020-0199openalex-snapshot
MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19
inferred← citeshttps://doi.org/10.17576/jsm-2023-5212-04openalex-snapshot
Characterisation of Recombinant 3CL Protease from SARS-CoV-2 Produced in E. coli BL21 (DE3) for Screening Anti-Covid Drug Candidates using Rhodamine 110-Synthetic Peptide Conjugate as A Substrate
inferred← citeshttps://doi.org/10.18203/2319-2003.ijbcp20203636openalex-snapshot
Is remdesivir the therapeutic answer for COVID-19: a review of current knowledge
inferred← citeshttps://doi.org/10.20944/preprints202004.0062.v1openalex-snapshot
Screening of FDA Approved Drugs Against COVID-19 Main Protease: Coronavirus Disease
inferred← citeshttps://doi.org/10.20944/preprints202004.0522.v1openalex-snapshot
Intermolecular Binding of Functional Cyclic Compounds to RNA Nucleotides by an Ionic Process
inferred← citeshttps://doi.org/10.21203/rs.3.rs-47356/v1openalex-snapshot
Effect of Ribavirin on Recovery Time in COVID-19 Patients: A Real-world Retrospective Cohort Study
inferred← citeshttps://doi.org/10.2174/1381612826999201116195851openalex-snapshot
Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19
inferred← citeshttps://doi.org/10.2174/1566524021666210203113849openalex-snapshot
Molecular Elucidation and Therapeutic Targeting for Combating COVID-19: Current Scenario and Future Prospective
inferred← citeshttps://doi.org/10.2174/1871526521666210301142223openalex-snapshot
A Mini Review on the Pathogenesis, Diagnosis and Treatment Options for COVID-19
inferred← citeshttps://doi.org/10.2174/2211352519666210506145558openalex-snapshot
Essentials in the Treatment of COVID-19
inferred← citeshttps://doi.org/10.2174/2405461507666220516092814openalex-snapshot
Green Synthesis of Copper Nanoparticles by Using Plant Extracts and their Biomedical Applications – An Extensive Review
inferred← citeshttps://doi.org/10.22541/au.158879190.06083691openalex-snapshot
Potential pharmacologic treatments for COVID-19 patients: A review study
inferred← citeshttps://doi.org/10.26434/chemrxiv.12044538.v2openalex-snapshot
Comparative Computational Study of SARS-CoV-2 Receptors Antagonists from Already Approved Drugs
inferred← citeshttps://doi.org/10.26434/chemrxiv.12044538.v4openalex-snapshot
Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs
inferred← citeshttps://doi.org/10.26434/chemrxiv.12278066openalex-snapshot
Repurposing of FDA Approved Drugs for the Identification of Potential Inhibitors of SARS-CoV-2 Main Protease
inferred← citeshttps://doi.org/10.26434/chemrxiv.12278066.v1openalex-snapshot
Repurposing of FDA Approved Drugs for the Identification of Potential Inhibitors of SARS-CoV-2 Main Protease
inferred← citeshttps://doi.org/10.26434/chemrxiv.12318689.v1openalex-snapshot
Molecular Docking Study of COVID-19 Main Protease with Clinically Approved Drugs
inferred← citeshttps://doi.org/10.26434/chemrxiv.13296524openalex-snapshot
Molecular Docking and Clinical Study of Inhibition of Phytochemical Compounds of Nigella Sativa, Matricaria Chamomilla and Origanum Vulgare L on COVID_19 Mpro
inferred← citeshttps://doi.org/10.33263/briac113.98279835openalex-snapshot
Molecular Docking Evaluation of Some Indonesian’s Popular Herbals for a Possible COVID-19 Treatment
inferred← citeshttps://doi.org/10.33333/rp.vol46n1.01openalex-snapshot
Compuestos Fitoquímicos Dirigidos al Bloqueo de la Polimerasa Viral del SARS-CoV-2 Causante del COVID-19: un Análisis Comparativo de Funciones de Puntuación para Acoplamientos con Interés Biomédico
inferred← citeshttps://doi.org/10.3389/fphar.2021.596855openalex-snapshot
Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective
inferred← citeshttps://doi.org/10.3390/jcm10163567openalex-snapshot
Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.3390/microorganisms8060850openalex-snapshot
From Wuhan to COVID-19 Pandemic: An Up-to-Date Review of Its Pathogenesis, Potential Therapeutics, and Recent Advances
inferred← citeshttps://doi.org/10.3390/molecules25081800openalex-snapshot
Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses
inferred← citeshttps://doi.org/10.3390/nano10040802openalex-snapshot
Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
inferred← citeshttps://doi.org/10.3390/nano10091645openalex-snapshot
Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?
inferred← citeshttps://doi.org/10.3390/v13030378openalex-snapshot
Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review
inferred← citeshttps://doi.org/10.34172/ps.2020.50openalex-snapshot
COVID-19: Clinical Characteristics and Molecular Levels of Candidate Compounds of Prospective Herbal and Modern Drugs in Indonesia
inferred← citeshttps://doi.org/10.4155/tde-2020-0035openalex-snapshot
COVID-19 Pandemic: an Overview of epidemiology, pathogenesis, Diagnostics and Potential Vaccines and Therapeutics
inferred← citeshttps://doi.org/10.4274/tjps.galenos.2021.83548openalex-snapshot
Molecular Docking Study of Several Seconder Metabolites from Medicinal Plants as Potential Inhibitors of COVID-19 Main Protease
inferred← citeshttps://doi.org/10.48550/arxiv.2003.09861openalex-snapshot
A SIDARTHE Model of COVID-19 Epidemic in Italy
inferred← citeshttps://doi.org/10.48550/arxiv.2006.01226openalex-snapshot
Repurposing drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2
inferred← citeshttps://doi.org/10.48550/arxiv.2102.04977openalex-snapshot
Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19
inferred← citeshttps://doi.org/10.48550/arxiv.2105.10489openalex-snapshot
Evening the Score: Targeting SARS-CoV-2 Protease Inhibition in Graph Generative Models for Therapeutic Candidates
inferred← citeshttps://doi.org/10.55007/dufed.1184096openalex-snapshot
Docking Studies of Natural Product Derived Carvacrol Type Aromatic Monoterpenes Against COVID-19 and Comparison with Used Synthetic Drugs: Potential of Carvacryl Acetate Against SARS-CoV-2 (COVID-19)
inferred← citeshttps://doi.org/10.5812/archcid.103537openalex-snapshot
Combination Therapy with Remdisivir and Tocilizumab for COVID-19: Lessons for Futures Studies
inferred← citeshttps://doi.org/10.5812/iji.106243openalex-snapshot
Potential Drugs for Treating COVID-19 Infection
inferred← citeshttps://doi.org/10.9734/jpri/2021/v33i37b32036openalex-snapshot
Covid - 19: Government Intervention and Post Covid Complications in India
showing the first 93 of 94 · page through all 94
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.